MADRID, Spain — Vitrase was shown to slow hemorrhage sufficiently to diagnose and treat vitreous hemorrhage, Marc de Smet, MD, said here during the Congress of the European Society of Ophthalmology.
WASHINGTON — An advertisement for Ista Pharmaceuticals’ product Vitrase, a formulation of ovine hyaluronidase, was called “false and misleading” in a letter to the company from federal regulators last ...
With a new drug application still under review for Vitrase in vitreous hemorrhage, ISTA Pharmaceuticals Inc. is asking the FDA to approve the drug as a spreading agent to facilitate the dispersion and ...
IRVINE, Calif., May 1 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. announced today details of two scientific poster presentations that describe the first ...
NEW YORK (CBS.MW) -- Ista Pharmaceuticals said Tuesday the U.S. Food and Drug Administration has granted it three years of market exclusivity for Vitrase, a spreading agent used to facilitate the ...
LONDON, GREATER LONDON, UNITED KINGDOM, February 7, 2025 /EINPresswire / -- What's the Anticipated Growth Rate and Market Size of the Global Vitrase Market? The Vitrase market has witnessed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback